Literature DB >> 12928836

Heart rate variability and Parkinson's disease severity.

D Devos1, M Kroumova, R Bordet, H Vodougnon, J D Guieu, C Libersa, A Destee.   

Abstract

Heart rate variability (HRV) decrease in Parkinson's disease (PD) could only be a consequence of reduce motor activity besides of being a marker of cardiovascular dysautonomia. Under continuously recorded and standardised motor activity, we studied thirty patients compared to controls in 3 PD stages: group I: less than 2 year-evolution, slight impaired without L-dopa; group II: mildly impaired with L-dopa; group III: advanced PD with motor complications. No difference was observed between group I and controls. The diurnal low frequency power (LF) and the ratio of LF/high frequency (HF) power decreased in groups II and III. The nocturnal vagal indicators: HF power and pNN50 were decreased in group III. Those parameters were correlated with Off-drug-motor handicap, suggesting an evolutive HRV decrease with disease severity but not with On-drug-motor activity. The low LF despite the higher motor activity in group III, due to dyskinesias, suggested a defective cardiovascular up-regulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12928836     DOI: 10.1007/s00702-003-0016-8

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  29 in total

1.  Olfactory dysfunction and cardiovascular dysautonomia in Parkinson's disease.

Authors:  Hisayoshi Oka; Chizuko Toyoda; Makiko Yogo; Soichiro Mochio
Journal:  J Neurol       Date:  2010-01-30       Impact factor: 4.849

2.  Cardiovascular variability in Parkinson's disease and extrapyramidal motor slowing.

Authors:  Rachael Brown; Stephen Duma; Olivier Piguet; G Anthony Broe; Vaughan G Macefield
Journal:  Clin Auton Res       Date:  2012-04-25       Impact factor: 4.435

Review 3.  'The clocks that time us'--circadian rhythms in neurodegenerative disorders.

Authors:  Aleksandar Videnovic; Alpar S Lazar; Roger A Barker; Sebastiaan Overeem
Journal:  Nat Rev Neurol       Date:  2014-11-11       Impact factor: 42.937

Review 4.  Circadian and sleep disorders in Parkinson's disease.

Authors:  Aleksandar Videnovic; Diego Golombek
Journal:  Exp Neurol       Date:  2012-08-23       Impact factor: 5.330

Review 5.  Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson's disease.

Authors:  Valerie Joers; Marina E Emborg
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-03-20

Review 6.  Thermodynamics in Neurodegenerative Diseases: Interplay Between Canonical WNT/Beta-Catenin Pathway-PPAR Gamma, Energy Metabolism and Circadian Rhythms.

Authors:  Alexandre Vallée; Yves Lecarpentier; Rémy Guillevin; Jean-Noël Vallée
Journal:  Neuromolecular Med       Date:  2018-03-23       Impact factor: 3.843

Review 7.  A New Perspective for Parkinson's Disease: Circadian Rhythm.

Authors:  Siyue Li; Yali Wang; Fen Wang; Li-Fang Hu; Chun-Feng Liu
Journal:  Neurosci Bull       Date:  2016-12-19       Impact factor: 5.203

8.  Subtle cardiovascular dysfunction in the unilateral 6-hydroxydopamine-lesioned rat.

Authors:  K Slack; R Billing; S Matthews; H N Allbutt; R Einstein; J M Henderson
Journal:  Parkinsons Dis       Date:  2010-03-21

Review 9.  Neurotrophic factors in autonomic nervous system plasticity and dysfunction.

Authors:  Mark P Mattson; Ruiqian Wan
Journal:  Neuromolecular Med       Date:  2008-01-03       Impact factor: 3.843

10.  Is heart rate variability related to gait impairment in patients with Parkinson's disease? A pilot study.

Authors:  M B Aerts; N E Synhaeve; A Mirelman; B R Bloem; N Giladi; J M Hausdorff
Journal:  Parkinsonism Relat Disord       Date:  2009-03-28       Impact factor: 4.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.